Cargando…
MON-137 Evaluation of the Timeliness of Serial Denosumab Administrations at the University of Colorado Hospital
BACKGROUND: Denosumab is an antiresorptive medication commonly used in the treatment of osteoporosis that works by slowing bone loss. This medication should not be delayed or interrupted without initiation of an alternative treatment (i.e. bisphosphonates) as studies have shown that this can lead to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207499/ http://dx.doi.org/10.1210/jendso/bvaa046.1327 |